Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure

Abstract Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF) remains unclear. Proteomics and metabolomics were integrated to in this study, as to describe AF patients’ dysregulated proteins and metabolites, comparing patients without HF to patients with HF. Methods...

Full description

Bibliographic Details
Main Authors: Haiyu Zhang, Lu Wang, Dechun Yin, Qi Zhou, Lin Lv, Zengxiang Dong, Yuanqi Shi
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12864-022-09044-z
_version_ 1811315307154767872
author Haiyu Zhang
Lu Wang
Dechun Yin
Qi Zhou
Lin Lv
Zengxiang Dong
Yuanqi Shi
author_facet Haiyu Zhang
Lu Wang
Dechun Yin
Qi Zhou
Lin Lv
Zengxiang Dong
Yuanqi Shi
author_sort Haiyu Zhang
collection DOAJ
description Abstract Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF) remains unclear. Proteomics and metabolomics were integrated to in this study, as to describe AF patients’ dysregulated proteins and metabolites, comparing patients without HF to patients with HF. Methods Plasma samples of 20 AF patients without HF and another 20 with HF were analyzed by multi-omics platforms. Proteomics was performed with data independent acquisition-based liquid chromatography-tandem mass spectrometry (LC-MS/MS), as metabolomics was performed with LC-MS/MS platform. Proteomic and metabolomic results were analyzed separately and integrated using univariate statistical methods, multivariate statistical methods or machine learning model. Results We found 35 up-regulated and 15 down-regulated differentially expressed proteins (DEPs) in AF patients with HF compared to AF patients without HF. Moreover, 121 up-regulated and 14 down-regulated differentially expressed metabolites (DEMs) were discovered in HF patients compared to AF patients without HF. An integrated analysis of proteomics and metabolomics revealed several significantly enriched pathways, including Glycolysis or Gluconeogenesis, Tyrosine metabolism and Pentose phosphate pathway. A total of 10 DEPs and DEMs selected as potential biomarkers provided excellent predictive performance, with an AUC of 0.94. In addition, subgroup analysis of HF classification was performed based on metabolomics, which yielded 9 DEMs that can distinguish between AF and HF for HF classification. Conclusions This study provides novel insights to understanding the mechanisms of AF-induced HF progression and identifying novel biomarkers for prognosis of AF with HF by using metabolomics and proteomics analyses.
first_indexed 2024-04-13T11:27:55Z
format Article
id doaj.art-c7407015d0d04d679230c9387815f0a7
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-04-13T11:27:55Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-c7407015d0d04d679230c9387815f0a72022-12-22T02:48:38ZengBMCBMC Genomics1471-21642022-12-0123111210.1186/s12864-022-09044-zIntegration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failureHaiyu Zhang0Lu Wang1Dechun Yin2Qi Zhou3Lin Lv4Zengxiang Dong5Yuanqi Shi6Key Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, the First Affiliated Hospital, Harbin Medical UniversityKey Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, the First Affiliated Hospital, Harbin Medical UniversityDepartment of Cardiology, the First Affiliated Hospital, Harbin Medical UniversityResearch Management Office, the First Affiliated Hospital, Harbin Medical UniversityKey Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, the First Affiliated Hospital, Harbin Medical UniversityKey Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, the First Affiliated Hospital, Harbin Medical UniversityKey Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, the First Affiliated Hospital, Harbin Medical UniversityAbstract Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF) remains unclear. Proteomics and metabolomics were integrated to in this study, as to describe AF patients’ dysregulated proteins and metabolites, comparing patients without HF to patients with HF. Methods Plasma samples of 20 AF patients without HF and another 20 with HF were analyzed by multi-omics platforms. Proteomics was performed with data independent acquisition-based liquid chromatography-tandem mass spectrometry (LC-MS/MS), as metabolomics was performed with LC-MS/MS platform. Proteomic and metabolomic results were analyzed separately and integrated using univariate statistical methods, multivariate statistical methods or machine learning model. Results We found 35 up-regulated and 15 down-regulated differentially expressed proteins (DEPs) in AF patients with HF compared to AF patients without HF. Moreover, 121 up-regulated and 14 down-regulated differentially expressed metabolites (DEMs) were discovered in HF patients compared to AF patients without HF. An integrated analysis of proteomics and metabolomics revealed several significantly enriched pathways, including Glycolysis or Gluconeogenesis, Tyrosine metabolism and Pentose phosphate pathway. A total of 10 DEPs and DEMs selected as potential biomarkers provided excellent predictive performance, with an AUC of 0.94. In addition, subgroup analysis of HF classification was performed based on metabolomics, which yielded 9 DEMs that can distinguish between AF and HF for HF classification. Conclusions This study provides novel insights to understanding the mechanisms of AF-induced HF progression and identifying novel biomarkers for prognosis of AF with HF by using metabolomics and proteomics analyses.https://doi.org/10.1186/s12864-022-09044-zAtrial fibrillationHeart failureProteomicsMetabolomicsBiomarkers
spellingShingle Haiyu Zhang
Lu Wang
Dechun Yin
Qi Zhou
Lin Lv
Zengxiang Dong
Yuanqi Shi
Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
BMC Genomics
Atrial fibrillation
Heart failure
Proteomics
Metabolomics
Biomarkers
title Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
title_full Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
title_fullStr Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
title_full_unstemmed Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
title_short Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
title_sort integration of proteomic and metabolomic characterization in atrial fibrillation induced heart failure
topic Atrial fibrillation
Heart failure
Proteomics
Metabolomics
Biomarkers
url https://doi.org/10.1186/s12864-022-09044-z
work_keys_str_mv AT haiyuzhang integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure
AT luwang integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure
AT dechunyin integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure
AT qizhou integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure
AT linlv integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure
AT zengxiangdong integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure
AT yuanqishi integrationofproteomicandmetabolomiccharacterizationinatrialfibrillationinducedheartfailure